Ivd Medical Holding Ltd., now known as ETHK Labs Inc., announced that its affiliate Shenzhen ICXIVD Biotechnology Co., Ltd., which was jointly established through strategic investment by ETHK Labs and iCarbonX, has successfully developed a dual-platform solution for Nipah virus detection. ICXIVD specializes in molecular diagnostics, integrating research and development, production, and technical services to provide comprehensive molecular diagnostic solutions. The core R&D team at ICXIVD brings expertise in in vitro diagnostic reagent development, genomics, bioinformatics, and artificial intelligence.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ivd Medical Holding Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260127-12002790), on January 27, 2026, and is solely responsible for the information contained therein.